German preclinical CRO NMI TT Pharmaservices is building a new branch at Bayer's new hub for biotech startups, hoping to expand the use of its discovery platform.
Called the CoLaborator, Bayer's recently opened Berlin outpost rents out lab space to small, innovative drug developers and allows them to work alongside the German giant's on-staff experts. NMI TT is joining the fold to offer its DigiWest multiplex protein profiling service, a drug discovery technology the company said can speed up early-stage research.
Setting up shop at CoLaborator presents an opportunity for the Reutlingen-headquartered CRO to raise its profile in Germany's biotech scene, NMI TT said, leveraging its relationship with Bayer to make new connections in the startup world.
"The chances of this new endeavor are manifold," NMI TT Berlin Site Head Christoph Sachse said in a statement. "We expect that being closer to the needs of pharma R&D scientists and the lively Berlin biotech community will substantially help us in further developing and in marketing our wide range of contract research offerings, in particular our multiplex protein profiling platform, but also our capabilities in cellular assays and in generating customized cell lines."
Unveiled last year, Bayer's Berlin CoLaborator is home to 5 startups with room for four more, offering shared lab and office space to its tenants. The site is modeled after Bayer's San Francisco-located U.S. Innovation Center, opened in 2011.
- read the statement